Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
Published Online: 2021-10-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Aiwu Ruth He•Allicia C Girvan•Amit Aggarwal•Arndt Vogel•Brian A Moser•Chunlao Tang•Crystal S Denlinger•Do-Youn Oh•Eric Van Cutsem•Harpreet Wasan•Jen-Shi Chen•Jiangang Liu•Joana M Oliveira•Jorge Adeva•Juan W Valle•Li-Tzong Chen•Li-Yuan Bai•Philip J Ebert•Radka Obermannova•Rashida Orlova•Richard A Walgren•Roberto Carlesi•Samuel C McNeely•Thomas J Ettrich•Wei Zhang
